La Vy, Nair Vishnu, Sunny Sini, Benharash Peyman, Thankam Finosh G
Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E. Second Street, Pomona, CA, 91766-1854, USA.
Department of Molecular, Cell, & Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Cardiovasc Drugs Ther. 2024 Nov 6. doi: 10.1007/s10557-024-07637-2.
Implications of epicardial adipose tissue (EAT) on the development of coronary artery disease (CAD) have garnered recent attention. Located between the myocardium and visceral pericardium, EAT possesses unique morphological and physiological contiguity to the heart. The transcriptome and secretome of EAT differ from that of other fat stores in the body. Physiologically, EAT protects the adjacent myocardium through its brown-fat-like thermogenic function and rapid fatty acid oxidation. However, EAT releases pro-inflammatory mediators acting on the myocardium and coronary vessels, thus contributing to the development and progression of cardiovascular diseases (CVD). Furthermore, EAT-derived mesenchymal stromal cells indicate promising regenerative capabilities that offer novel opportunities in cell-based cardiac regeneration. This review aims to provide a comprehensive understanding and unraveling of EAT mechanisms implicated in regulating cardiac function and regeneration under pathological conditions. A holistic understanding of the multifaceted nature of EAT is essential to the future development of pharmacological and therapeutic interventions for the management of CVD.
心外膜脂肪组织(EAT)对冠状动脉疾病(CAD)发展的影响最近受到了关注。EAT位于心肌和脏层心包之间,与心脏具有独特的形态和生理连续性。EAT的转录组和分泌组不同于体内其他脂肪储存。生理上,EAT通过其类似棕色脂肪的产热功能和快速脂肪酸氧化来保护相邻的心肌。然而,EAT会释放作用于心肌和冠状动脉血管的促炎介质,从而促进心血管疾病(CVD)的发展和进展。此外,EAT来源的间充质基质细胞显示出有前景的再生能力,为基于细胞的心脏再生提供了新的机会。本综述旨在全面理解和阐明EAT在病理条件下调节心脏功能和再生的机制。全面了解EAT的多方面性质对于未来开发用于管理CVD的药理和治疗干预措施至关重要。